5-nitro-imidazoles as antimicrobial agents

ABSTRACT

PHARMACEUTICAL COMPOSITIONS COMPRISING 5-NITRO-IMIDAZOLES OF THE FORMULA   1-X,2-((2-Y,R1,R2,R3-PHENYL)-CO-C(-Z)=CH-),5-NO2-IMIDAZOLE   WHEREIN X IS HYDROCARBON OR A FREE OR ESTERIFIED HYDROXY GROUP; Y AND Z EACH ARE H OR, COLLECTIVELY, A BRIDGING FROUP CONSISTING OF -CH2- AND OR ONE OF O, S, SO AND SO2, -CH2CH2-, OR -CHA- WHEREIN A IS -CH3, -C2H5 OR -C6H5; R1 AND R2 EACH ARE ALKYL HALOGEN OR FREE, ESTERIFIED OR ETHERIFIED -OH; AND R3 IS H, ALKYL SUBSTITUTED ALKYL, HALOGEN, FREE, STERIFIED OR ETHERIFIED -OH, AMINO, AMIDO OR AMINOALKOXY; IN ADMIXTURE WITH A PHARMACEUTICALLY ACCEPTABLE CARRIER, AND THEIR USE FOR THE TREATMENT OF TRICHOMONIASIS.

nited States Patent Ofiice Patented June 4, 1974 US. Cl. 424-248 10 Claims ABSTRACT OF THE DISCLOSURE Pharmaceutical compositions comprising S-nitro-imidazoles of the formula wherein X is hydrocarbon or a free or esterified hydroxy group; Y and Z each are H or, collectively, a bridging group consisting of -CH and/ or one of O, S, SO and S0 CH CH or -CHA-- wherein A is CH C H or --C H R and R each are alkyl, halogen or free, esterified or etherified OH; and R is H, alkyl, substituted alkyl, halogen, free, esterified or etherified- OH, amino, amido or aminoalkoxy; in admixture with a pharmaceutically acceptable carrier, and their use for the treatment of trichomoniasis.

BACKGROUND OF THE INVENTION This invention relates to pharmaceutical compositions comprising novel S-nitro-imidazoles and their use in the treatment of trichomoniasis. This is a continuation-in-part of Application Ser. No. 53,298, filed July 8, 1970, now US. 3,721,668.

The etfectiveness of nitroimidazoles against trichomonads has been known since the discovery of the antibiotic azamycin (2-m'troimidazole, S. Nakamura and H. Umezawa, J. Antibiotics (Tokyo), 9 A, 66 [1955]). However, these and other 2-nitroimidazoles have proved to be of relatively limited usefulness. See G. C. Lancini, E. Lazzari, R. Pallanea, ll Farmaco Ed. Sc. 21, 278 (1966). As the best among a large number of synthesized compounds (C. Cosar, Arzneimittelforschung" [Drug Research] 16, 23 [1966]), only the commercial preparation metronidazole 1- (Z-hydroxyethyl) 2-methyl- S-m'troimidazole; see, e.g., French Pat. 1,212,028) has evolved from the 5-nitroimidazoles.

It has now been found that the condensation products as defined herein of the l-substituted 5-nitro-2-imidazoly1 aldehydes with ketones containing active methylene groups exhibit a far stronger activity against Trichomonas vaginalis than metronidazole. Moreover, they exhibit antibacterial and antifungal eifectiveness and are also active against other protozoa.

SUMMARY OF THE INVENTION The compounds of the pharmaceutical compositions of this invention can be represented by the formula wherein X is a saturated or unsaturated hydrocarbon group containing 1 to 5 carbon atoms or free or esterified 2-hydoxyethyl group Y and Z each are hydrogen atoms or, collectively, a ringforming (a) -CH (b) one of -O-, S-, -SO and SO;,,, (c) a combination of (a) and (b), (d) CH CH or (e) -CHA wherein A is CH C H or C H R R and R each are H, alkyl containing 1 to 5 carbon atoms, halogen, or a free, esterified or etherified hydroxy group; and, additionally, R can be corresponding alkyl substituted in the terminal position by halogen or a free, esterified or etherified hydroxy group as defined herein, or a primary, secondary or tertiary amino or aminoalkoxy group or an amide group, and the acid addition salts and the quaternary ammonium salts thereof.

DETAILED DISCUSSION In the compounds of Formula I, X can be saturated or unsaturated. Examples of X which are saturated hydrocarbon are methyl, ethyl, isopropyl, butyl, sec.-butyl, iso-butyl, tert.-butyl, hexyl, heptyl, octyl, nonyl and decyl. Examples of unsaturated hydrocarbon are ethenyl, ethynyl, allyl, propynyl, l-methylallyl, crotyl, butadienyl, 2-octenyl, 6-octenyl, etc. Preferred are those containing 1-4 carbon atoms and a single unsaturation, preferably a double bond in the ,8-position.

When is a 2-hydroxyethyl group in the compounds of this invention, the OH group can be free or esterified to form a benzoyloxyethyl or an alkanoyloxyethyl group of the formula alkyl-COOCH CH containing 1 to 5 carbon atoms in the alkyl group.

Y and Z can each be a hydrogen atom, or collectively, a bridging, ring-forming group containing one or two ring members which" are OCH CH -O--, SOCH SO -CH CH SO-,

' In the compounds of this invention R R and R each can be H, an alkyl group of 1 to 5 carbonatoms as illustrated above for X, halogen, viz., Cl, Br, I or F, or a free, esterified or etherified OH group. Additionally, R can be a primary, secondary or tertiary amino, amido, aminoalkoxy or amidoalkoxy group.

When R or R is an etherified OH group, the ether group can be alkoxy containing 1 to 5 carbon atoms, e.g., methoxy, ethoXy, propoxy, isopropoxy, butoxy, tertiarybutoxy, amyloxy, and the like or other ether group as illustrated hereinafter for R When R or R is an esterified -OH group, the ester group can be an acyloxy group of the formula alkyl COO containing 1 to 5 carbon atoms in the alkyl group or other esterified hydroxy group illustrated hereinafter for R When R is an esterified hydroxy group, the ester group can be an ester of an aliphatic or aromatic carboxylic or sulfonic acid containing 1 to 10 carbon atoms, such as, for example, acetic acid, butyric, benzoic acid, cinnamic acid, methanesulfonic acid, p-toluenesulfonic acid, or butanesulfonic acid.

Other examples of esterified hydroxy R groups are those in which the ester group is acyloxy wherein the acyl group is the acyl radical of, for example, a loweraliphatic acid, e.g., formic, propionic, butyric, isobutyric, valeric, isovaleric, trimethylacetic, 2-methylbutyric, 3- ethylbutyric, hexanoic, diethylacetic, triethylacetic, heptanoic, octanoic, u-ethylisovaleric, acyclic acid, e.g., cyclopropylideneacetic, a cycloaliphatic acid, e.g., cyclopentylformic, cyclopentylacetic, fi-cyclopentylpropionic, cyclohexylformic, cyclohexylacetic, fi-cyclohexylpropionic, an aryl or alkaryl acid, e.g., 2, 3, or 4-methylbenzoic, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- and 3,5-dirnethylbenzoic, ethylbenzoic, 2,4,6-trimethylbenzoic, 3-methyl-m-naphthoic, an aralkyl acid, e.g., phenylacetic, phenylpropionic, a dibasic acid, e.g., succinic, glutaric, a-methylglutaric, fl-methylglutaric, fiLB-dimethylglutaric, adipic, pimelic, suberic, a hydroxy acid, e.g., glycolic, lactic, citric, tartaric, d-maleic, dglyceric, mannonic, gluco'nic, salicylic, an amino acid, e.g., glycine, diglycollamic, triglycollamic, methylglycine, dimethylglycine, diethylglycine, para-aminosalicylic, paraaminobenzoic, other hetero-substituted acids, e.g., ethylmercaptoacetic, benzylmercaptoacetic, cyanoacetic, chloroacetic, fluoroacetic, trichloroacetic, trifluoroacetic, thioglycolic, I 2,3,4-trimethoxybenzoic, u-naphthoxyacetic, ,6- pyrrolidylpropionic, carbamic acids, e.g., carbamic acid, phenylcarbamic, n-butylcarbamic, dimethylcarbamic, diethylcarbamic, allophanic, or a heterocyclic acid, e.g., ,8- furylcarboxylic, N-methylpyrrolidyl 2 carboxylic, apicolinic, indole-2-carboxylic, 6-hydroxyindolyl-3acetic, N-methylmorpholyl 2 carboxylic and pyrrolyl-2-carboxylic acid.

Other examples of esterified R --OH groups in which the ester is a sulfonyloxy group are those in which the sulfonyl group is arylsulfonyl, e.g., benzenesulfonyl, m, mdimethylbenzenesulfonyl, 0,0 dimethylbenzenesulfonyl, sym.-trimethylbenzenesulfonyl, sym. triethylbenzenesulfonyl, m-ethylbenzenesulfonyl, para-isopropylbenzenesulfonyl, m-n-butylbenzenesulfonyl, or is alkylsulfonyl, e.g., ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, tert.-butylsulfonyl, isoamylsulfonyl, hexylsulfonyl, heptylsulfonyl, octylsulfonyl, or heterocyclic sulfonyl, e.g., u-pyridinesulfonyl, a-pyranesulfonyl, a-thiophenesulfonyl, a-furansulfonyl, u-tetrahydrofuransulfonyl, or other alkyl-, carbocyclic and heterocyclic aryl-, alkaryland aralky1-sulfonyl group, preferably one containing 1-8 carbon atoms and -2, preferably 0-1 N, S or O hetero atoms, which are preferably ring carbon atoms, in the heterocyclic ring (R' group).

When R is an etherified hydroxy group, the etherifying group can be alkyl containing 1 to carbon atoms, e.g., methyl, ethyl, propyl, isopropyl, butyl, iso-butyl, tert.-butyl, isoamyl and amyl, alkenyl, e.g., allyl or aralkyl, e.g., benzyl.

In the compounds of this invention R; can also be a primary, secondary or tertiary amino group or aminoalkoxy group.

Preferred N-substituted amino groups are monoand dialkylamino groups wherein each alkyl group contains 1 to 5 carbon atoms, e.g., methylamino, ethylamino, npropylamino, isopropylamino, butylamino, isobutylamino, amylamino, dimethylamino, methylethylamino, diethylamino, methyl-n-propylamino, dipropylamino, diisopropylamino, methyl-isobutylamino, di-n-butylamino and methyl-amylamino.

Other examples of substituted amino are those wherein the amino nitrogen atom is mono-substituted or disubstituted with saturated hydrocarbon other than alkyl, or unsaturated hydrocarbon, containing 1 to 5 carbon atoms or, together with the N-atom, forms a heterocyclicamino substituent containing, e.g., 4 to 14, preferably 4 to 6 carbon atoms and 1 to 3, preferably 1 or 2 heteroatoms including the amino nitrogen atom and 0 to 3, preferably 0 to 1 rings, which substituent can be substituted by one or more alkyl groups of 1 to 5 carbon atoms, and contain a N-, O- or S-atom in addition to the amino nitrogen atom as a ring member, e.g., pyrrolidino, 2-methylpyrrolidino, 2,5-dimethylpyrrolidino, 3-ethylpyrrolidino, piperidino, homopiperidino, morpholino, imidazole, triazole, tetrazole, oxazole, dioxazole, isothiozole, pyridazine, pyrimidine, piperazine, isoxazine, morpholine, indole, benzoxazine, anilino, N-lower-alkylanilino, benzylamino, N- lower-alkyl-benzylamino, o-toluidino, p-toluidino and N- lower-alkyl-phenylethylamino.

R can also be a corresponding amido group, e.g., an acylated or sulfonylated amino group, e.g., wherein the acyl or sulfonyl group is acetyl-, propionyl-, butyryl-, methanesulfonyl-, benzenesulfonyl-, toluenesulfonyl or other acyl or sulfonyl group as defined hereinabove.

R can also be an aminoalkoxy group wherein the alkoxy group contains 2 to 5 carbon atoms, preferably 2, and the amino group is a primary, secondary or tertiary amino group as defined above.

Preferred of the N-substituted aminoalkoxy groups are saturated and unsaturated monoand dialkylaminoethoxy, free and esterified monoand di-(hydroxyalkyD-aminoethoxy, monoand di-(acyloxyalkyU-aminoethoxy, monoand dicycloalkylaminoethoxy, pyrrolidinoethoxy, piperidinoethoxy, hexa-, octaand decamethyleniminoethoxy, piperazinoethoxy and morpholinoethoxy wherein the alkyl groups contain 1 to 5 carbon atoms and the cycloalkyl group contains 5 or 6 carbon atoms. The cyclicamino groups can be substituted on a ring carbon atom and the N'-amino nitrogen atom, in the case of the piperazine ring, by alkyl, hydroxy, acyloxy, acyl, hydroxyalkyl or acyloxyalkyl containing 1 to 5 carbon atoms in the alkyl and/or acyl groups, and can be bridged directly or via an alkylene group.

The following are preferred classes of compounds of this invention defined by Formula I:

(a) X=alkyl containing 1 to 4 carbon atoms, prefer ably CH (b) X=alkyl;

(0) Y and Z are -CH i.e., l-indanones;

(d) Y and Z are --CH CH i.e., l-tetralones;

(e) Y and Z are 0, i.e., 3-benzofuranones;

(f) Y and Z are CH -S-, i.e., 4-thiachromanones;

(g) Y and Z are H, i.e., acetophenones;

(h) at least one, preferably one or two of R R and R are H;

(i) one or two of R R and R is H and the remainder are free, esterified or etherified hydroxy, preferably wherein any esterified hydroxy is acetoxy and any etherified hydroxy is lower-alkoxy, especially methoxy, or B-tert.- aminoethoxy, p-hydroxyethoxy or ,B-acyloxyethoxy;

(j) combinations of (c), (d), (e), (f) and (g) with one or both of (a) and (h) or (i);

(k) pharmaceutically acceptable, i.e., physiologically acceptable, acid addition salts of each of the above classes of compounds, especially hydrochlorides.

The compounds of this invention are preferably isolated and administered in the form of an acid addition salt, e.g., inorganic acids, including hydrochloric acid, hydrobromic acid, nitric acid, sulfuric acid, phosphoric acid, organic acids, including lactic acid, acetic acid, propionic acid, citric acid, benzoic acid, succinic acid, heptagluconic acid, etc. Preferred are the pharmaceutically acceptable acid addition salts, i.e., those formed with acids which do not materially increase the toxicity of the free base form thereof. However, acid addition salts of toxic acids, e.g.,

. perchloric, picric, etc., can be used for isolation, purification and/or characterization purposes and are also embraced within the scope of this invention.

Quaternary ammonium salts of the compounds of this invention formed by reaction with e.g., an alkyl halide, aralkyl halide, dialkyl sulfate, alkyl sulfonate, preferably loweralkyl halides, also possess activity against trichomonas vaginalis and are included within the scope of this invention. When a compound of this invention possesses two basic amonio groups, obviously the quaternary ammonium form of both amino groups can be formed. Examples of quaternary ammonium groups are tri-methylammonium iodide, trimethylammonium sulfate; ethyldimethylammonium bromide, benzyldimethylammonium chloride- N-ethyl-pyrrolidinium iodide and other, e.g., lower alkyl ammonium chlorides, bromides, iodides and sulfates of the free base form of thecompounds of this invention described in the examples which follow.

The novel compounds can be prepared by the following methods:

(a) Analdehyde of the formula 'N o N "-0110 wherein X has the values given above, or a functional derivative of the aldehyde, is reacted with a compound of the formula I R1 Z R: III

wherein Y, Z, R R and R have the values given above,

and thereafter a free hydroxyl or amino group is option-v ally acylated or sulfonylated; or acylated or sulfonylated products are saponified; or a hydroxyl group is exchanged for a halogen atom; or sulfonyloxy or halogen compounds are reacted with primary or secondary amines, and/or optionally, the amino compounds are converted into the salts thereof with organic or inorganic acids, with alkyl halides, dialkyl sulfates, or alkyl sul-fonates;

(b) a compound of the formula wherein X and R, R and R have the values given above and D represents one of the groups S, S-CH and -CH -S, so as to convert the thio group to a sulfoxide or sulfonyl compound.

The process according to (a) can be conducted at room temperature or at an elevated temperature in an acidic reaction medium, preferably in the anhydride of an aliphatic carboxylic acid of l-5 carbon atoms or in glacial acetic acid in the presence of concentrated sulfuric acid.

The condensation can also be conducted in HCl-containing ethanol, in formic acid, in orthophosphoric acid, and in piperidine/glacial acetic acid. Any acylation of hydroxyl groups or amino groups Occurring during the reaction can, if desired, be reversed by saponification. On the other hand, the preparation of acylated products can be conducted by effecting the condensation in the pres ence of the anhydride of the acid desired for the acylation when the acid is aliphatic and contains 1-6 carbon atoms, or by reacting free hydroxyl or amino groups with the corresponding acid chloride and anhydride, respectively. Products in which R is an aminoalkoxy group can also be obtained by reacting the corresponding tosyloxy or halogen compound of Formula I with an amine, the halogen compounds preferably being prepared from the corresponding hydroxyl compounds with halogenating agents, such as, for example, thionyl chloride or bromide.

The salt formation of the compounds containing amino groups can likewise be conducted subsequently, as in process (a).

Preferred functional derivatives of the starting aldehydes (II) are the diacetates.

The nitration according to process (b) can be conducted in accordance with the conventional methods, for example, with nitric acid in concentrated sulfuric acid or in the presence of the BF -N O complex. Process (b) generally, gives less satisfactory results than process (a).

The oxidation of the sulfur atom, according to process (c), to the sulfoxide or sulfone can be conducted, for example, with hydrogen peroxide or an organic peracid.

The novel compounds exhibit good antibacterial and antifungal effects and are especially effective against protozoa and, among the latter, specifically effective against T richomonas vaginalis. Table I illustrates the superior effect of the compounds of this invention against Trichomonas vaginalis, compared to the conventional commercial preparation metronidazole used in trichomoniasis. (This compound is described in French Pat. 1,212,028, published on Mar. 21, 1960. With respect to the effectiveness of this compound and numerous other S-nitroimidazoles, none of which was more active than the former, see C. Cosar Arzneimittelforschung" [Drug Research] 16, 23 [1966].)

TABLE I Minimum inhibitory concentration in 7/ ml. against Compound Trichomonas vaginalis 6,7-dimethoxy 2 (S-nitro-1-methyl-2-imidazolylmethylene)-3-benzofuranone 0.024 6-hydroxy-2-(5-nitro 1 methyl 2 imidazolylmethylene)-l-tetralone 0.024 6-acetoxy 5 methoxy-2-(5-nitro-1-methyl-2-imidazolyl-methylene)-1-indanone 0.012 5-acetoxy-2-(5-nitro 1 allyl-Z-imidazolyl-methylene)-1-indanone 0.024 4,5-dimethoxy-2-(5-nitro 1 methyl-Z-imidazolylmethylene)-1-indanone 0.049 Z-(S-nitro 1 methyl-Z-imidazolyl-methylene)-4- thiachromanone 0.012

4-(2-acetoxyethoxy)-2-(5 nitro-1-methyl-2-imidazolyl-methylene)-acetophenone 0.049 Metronidazole (in own test) 1.56

The toxicity of the compounds of this invention is low, as evidenced by the fact they are well tolerated by mice upon an oral administration of 1 g./kg.

The compounds of Formula I are useful in the treatment of Trichomonas vaginalis infections. For such use,

they can be formulated into conventional drug forms with the additives, carrier substances, and flavoring agents customary in pharmaceutical preparations which do not deleteriously react with the effective agents, employing conventional methods. For oral application, particularly 7 suitable are tablets, dragees, capsules, pills, suspensions and solutions. Such compositions can employ, for example, water, alcohol, polyethylene glycols, gelatin, sucrose, lactose, amylose in solutions and suspensions and magnesium stearate, talc, starch, sugars, etc., in tablets. The

concentration of the effective agent in the thus-formulated compositions is dependent on the activity of the specific compound employed, the responsiveness of the individual patient and the mode of administration.

Tablets usually contain, for example, 0.1-0.5 g. of effective agent and 0.1- g. of a pharmacologically inactive excipient.

For topical application, the compounds of this invention can be applied as a powder, solution suspension, foam or aerosol or as vaginal tablets and suppositories. For parenteral application, aqueous or oily solutions or suspensions can be used.

In the following examples, the temperatures are set forth in degrees centigrade.

Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.

EXAMPLE 1 405 mg. (2.5 millimols) of 5-methoxy-l-indanone, 388 mg. (2.5 mmol) of S-nitro-l-methyl-Z-imidazolyl aldehyde, and 350 mg. of anhydrous sodium acetate were allowed to stand in 2.5 ml. of acetic anhydride for 90 minutes at 70 C. After cooling to 5 vacuum-filtering, and washing with water, as well as digesting in boiling ethanol, 235 mg. (32% of theory) of S-methoxy-Z-(S-nitro-lmethyl-Z-imidazolyl-methylene) l-indanone was obtained, M.P. 256--258.

C H N Calculated 60. 19 4. 38 14. 04

Found 60. 44 4. 22 13.94

EXAMPLE 2 81 mg. (0.5 mmol) of S-methoxy-l-indanone and 78 mg. (0.5 mmol) of S-nitro-1-methyl-2-imidazolyl aldehyde were boiled in 2 ml. of 75% aqueous ethanol with 0.05 ml. of concentrated hydrochloric acid for 3 hours. After cooling to 20 and working the reaction mixture up as described in Example 1, mg. (6.8% of theory) of 5 methoxy 2 (5 nitro 1 methyl 2 imidazolylmethylene)-l-indanone was obtained.

EXAMPLE 3 81 mg. (0.5 mmol) of S-methoxy-l-indanone and 78 mg. (0.5 mmol) of 5-nitro-l-methyl-Z-imidazolyl aldehyde were boiled for 1 hour in 1 ml. of formic acid. After cooling to 20 and working up the reaction mixture as described in Example 1, mg. (10% of theory) of 5- methoxy 2 (5 nitro 1 methyl 2 imidazolylmethylene)-1-indanone was obtained.

EXAMPLE 4 allowed to stand in 2.5 ml. of acetic anhydride for 90 minutes at 100. The reaction mixture was cooled, vac- 8 uurn-filtered, and washed with 5 ml. of water. After recrystallization, 125 mg. (19% of theory) of S-nitro-l-methyl- 2 diacetoxymethyl-imidazolewas obtained, M.P. 144- 146.

81 mg. (0.5 mmol) of S-methoxy-l-indanone and mg. (0.5 mmol) of 5-nitro-1-methyl-2-diacetoxymethylimidazole, as well as 70 mg. of anhydrous sodium acetate were reacted in 0.5 ml. of acetic anhydride, as described in Example 1, and worked up, thus obtaining 240 mg. (33% of theory) of 5 methoxy 2-(5-uitro-1-methyl-2- imidazolyl-methylene)-1-indanone.

EXAMPLE 6 330 mg. of indanone was reacted and worked up as described in Example 1, thus obtaining 322 mg. (48% of theory) of 2 (5 nitro-1-methyl-2-imidazolyl-methylene)-1-indanone, M.P. 250254.

C H N Calculated 62.44 4.12 15.60

Found 62.27 4.39 15.80

EXAMPLE 7 c H N Calculated 01.33 4.83 13.41

Found 01.70 4.86 13.54

EXAMPLE 8.

510 mg. of 5-butoxy-2-indano'ne was reacted and worked up as described in Example 7, thus obtaining 259 mg. (30% of theory) of 5-butoxy-2-(5-nitro-1-methyl-2- imidazolyl-methylene)-1-indanone, M.P. 243-246".

C H N Calculated 63. 32 5. 62 12. 31

Found 63. 87 5. 12. 69

EXAMPLE 9 370 mg. of S-hydroxy-l-indanone was reacted as. described in Example 7. The crude product was recrystallized from dimethylformamide, thus obtaining 324 mg. (40% of theory) of 5 acetoxy 2-(5-nitro-1-methyl-2- imidazolyl-methylene) l-indanone, M.P. 244-248 c I H N Calculated 58.71 4.01 12.84

Found. 59.02 4.20 13.04

EXAMPLE l0 370 mg. of ,4-hydroxy-1-indanone was reacted as set forth in Example 7. The'crude product was digested with methanol, thus obtaining 540 mg. (67% of theory) of 4- acetoxy 2 (5 nitro-1-methyl-2-imidazolyl-methylene)- l-indanone, M.P. 241-243.

o H N Calculated 58.71 4.01 12.84

Found. 5am 3.95 13.03

EXAMPLE 11 540 mg. (1.65 mmol) of 4-acetoxy-2-(S-nitro-I-methyl- 2 irnidazolyl-methylene)-l-indanone wasboiled for 2 hours in 13.5 ml. of ethanol with 6.8 ml. of concentrated hydrochloric acid. The reaction mixture was cooled, vacu- 9 um-filtered, and recrystallized from dimethylformamide, thus obtaining 276 mg. (59% of theory) of 4-hydroxy-2- (5 nitro 1 methyl 2 imidazolylmethylene)-1- indanone; M.P. 285--287.

Calculated 58.94 ass 14.73

Found 59.17 4.00 14.77

EXAMPLE 12 480 mg. of 4,5-dirnethoxy-1-indanone was reacted and worked up as described in Example 7, thus obtaining 425 mg. (52% of theory) of 4,5-dimethoxy-2-(S-nitro-lmethyl 2 imidazolyl-methylene)-l-indanone; M.P. 228- C H N Calculated 58. 36 4. 60 12. 76 Found 58. 37 4. 42 12. 71

EXAMPLE 13 365 mg. of 6-methyl-1-indanone was reacted as set forth in Example 7. The crude product was recrystallized from a mixture of acetonitrile-chloroform-tetrahydrofuran, 25:30:10. 133 mg. (19% of theory) of 6-methyl- 2-(5-nitro-l-methyl 2 imidazolyl-methylene) 1 indanone was obtained; M.P. 249-252".

C H N Calculated 63. 59 4. 63 14. 83

Found 64. 13 4. 68 14. 90

EXAMPLE 14 455 mg. of -methoxy-6-hydroxy-l-indanone was reacted as described in Example 7. The crude product was digested with methanol and recrystallized from dirnethylformamide, thus obtaining 260 mg. (30% of theory) of 5-methoxy-6-acetoxy-2-(S-nitro 1 methyI-Z-imidazolylmethylene)-1-indanone. M.P. 248-252.

o H N Calculated 57.14 4.24 11.70

Found 57.45 4.17 11.78

EXAMPLE 15 590 mg. of 5-methoxy-6-acetoxy-2-(S-nitro-ll-methyl- 2-imidazolyl-methylene 1 indanone was reacted and worked up as described in Example 11, thus obtaining 396 mg. (76% of theory) of S-methoxy-G-hydroxy-Z (S-nitro 1 methyl 2 imidazolyl-methylene)-l-indanone, M.P. 290.

C H N Calculated 57.14 4.16 13.33

Found 57. 76 4. 25 13. 46

EXAMPLE 16 415 mg. of 6-chloro-1-indanone was reacted as set forth in Example 7. The crude product was digested with acetonitrile, thus obtaining 431 mg. (57% of theory) of 6- chloro-2-(5-nitro-1-methyl 2 imidazolyl-methylene)-1- indanone; M.P. 258259.

C H N Calculated 55.36 3.34 13. 86 Found 54. 76 3. 35 14. 12

EXAMPLE 17 540 mg. of 5-acetoxy-2-(5-nitro-1-methyl-2-imidazolylmethylene)-l-indanone was reacted and worked up as described in Example 11, thus obtaining 420 mg. (90% of 1 0 theory) of 5-hydroxy-2-(5-nitro 1 methyI-Z-imidazolylmethylene)-1-indanone; M.P. 292.

Calculated 58. 94 3.89 Found 58. 38 4. 19

EXAMPLE 18 370 mg. of 7-hydroxy-1-indanone was reacted as set forth in Example 7. The crude product was recrystallized from a mixture of acetonitrile-chloroform, 1:1, thus obtaining 180 mg. (22% of theory) of 7-acetoxy-2-(5-nitro- 1-methyl-Z-imidazolyl-methylene)-l-indanone; M.P. 225- 229.

Calculated... 58.94 3.89

Found 58.38 H 4.19

EXAMPLE 19' 485 mg. of 7-acet'oxy-1-indanone was reacted as described in Example 7. The crude product was digested with methanol, thus obtaining mg. (10% of theory) of 7-acetoxy 2 (S-nitro-1-methyl-2-imidazolyl-methylene) -1-indanone.

EXAMPLE 20 550 mg. of 5-(2-ethoxyethoxy)-1-indanone was reacted and worked up as described in Example 7, thus obtaining mg. (11% of theory) of- 5-(2-ethoxyethoxy)-2-(5- nitro 1 methyl 2 imidazolyl-methylene) 1 indanone, M.P. 220-222.

C H N Calculated 60.49 5.36 11.76

Found. 59.91 5.56 11.56

EXAMPLE 21 365 mg. of 3methyl-1-indanone was reacted and worked up as set forth in Example 7, thus obtaining 100 mg. (14% of theory) of 3-methyl-2-(S-nitro-l-methyl-Z- imidazolyl-methylene)-1-indanone, M.P. 215-2 16.

o H N Calculated 63.62 4.63 14.83

Found 63.83 4.62 14.94

EXAMPLE 22 375 mg. of 6-hydroxy-3-benzofuranone was reacted as described in Example 1. The crude product was recrystallized first from a mixtureof methanol-chloroform, 1:1, and then from dimethylformamide. 270 mg. (33% of theory) of 6-acetoxy 2 (S-nitro-l methyl Z-imidazolyl- 542 mg. of 6-acetoxy-2-(S-nitro-l-methyl-Z-imidazolylmethylene)-3;benzofuranone was reacted and worked up as set forth in Example 11, thus obtaining 207 mg. (44% of theory) of 6-hydroxy-2-(S-nitro-I-methyI-Z-imidazolylmethylene)-3-benzofuranone, M.P. 290.

O H N Calculated 54.36 3.16 14.63

Found 53.86 3.38 14.70

EXAMPLE 24 350 mg. of thioindoxyl was reacted as described in Example 7. The crude product was digested with dirnethylformamide, thus obtaining 132 mg. (18% of theory) of 2-(5-nitro 1 methyl 2 imidazolyl-methylene)-thioindoxyl; M.P. 283288.

see:

Calculated F d 54. oun 54 EXAMPLE 25 541 mg. of 7-acetoxy-2-(S-nitro-l-methyl-Z-imidazolylmethylene)-1-indanone was reacted as set forth in Exampie 11. The crude product was digested with ethanol, thus obtaining 271 mg. (97% of theory) of 7-hydroxy-2-(5- nitro-1-methyl-Z-imidazolyl-methylene)-l-indanone; M.P. 265-268.

o H N Calculated 58.94 3.30 14.73

Found 50.32 3.55 14.00

EXAMPLE 26 365 mg. of 4-methyl-1-indanone was reacted as described in Example 7. After digesting in hot dimethylformamide, 213 mg. (30% of theory) of 4-methyl-2-(5- nitro-1-methyl-2-imidazolyl-methylene)-1 indanone was obtained; M.P. 254-255".

Calculated 03.59 4.03 14.33

Found 03.73 4.80 14.58

EXAMPLE 27 435 mg. of fi-isopropyl-l-indanone was reacted and worked up as described in Example 26, thus obtaining 242 mg. of 6-isopropyl-2-(S-nitro-1-n1ethyl-2-imidazolyl methylene)-1-indanone (31% of theory); M.P. 243/50- 255.

Calculated 05.59 5.51 13.50

Found 05.50 5.07 13.40

EXAMPLE 28.

407 mg. of 4-methoxy-1-indanone was reacted and worked up as described in Example 26, thus obtaining 209 mg. (28% of theory) of 4-methoxy-2-(5-nitro-1- methyl-Z-imidazolyl-methylene)-1-indanone; MJP. 259- 264. I

O H N Calculated 60.19 4.38 14.04

Found 60.00 4.50 13.93

EXAMPLE 29 470 mg. of S-allyloxy-Lindanone was reacted and worked up as described in Example 26, thus obtaining 176 mg. (22% of theory) of -allyloxy-2-(5-nitro-1-methy1-2- imidazolyl-methylene)-1-indanone, M.P. 256-260".

C H N Calculated 62. 76 4.65 12.92

Found 62.89 4.61 12.95

EXAMPLE 30 594 mg. of S-benzoxy-l-indanone was reacted and worked up as set forth in Example 26, thus obtaining 159 mg. (22% of theory) of 5-allyloxy-2-(S-nitro-l-methyl-Z- imidazolyl-methylene)-1-indanone, M.P. 256-260.

c H N Calculated 57.20 4.57 11.21 Found 57.25 4.30 11.20

EXAMPLE 31 415 mg. of 4-chloro-1-indanone was reacted and worked up as described in Example 26, thus producing 166 mg. (22% of theory) of 4-chloro-2-(5-nitro-1-methyl-2-imidazolyl-methylene l-indanone, M.P. 239/ 44-249 C H N Calculated...; 55.36 3.34 13.83

Found 55.29 3.24 13.84.

EXAMPLE 32 480 mg. of' 5,6-dimethoxy-1-indanone was reacted and worked up as set forth in Example 26, thus obtaining 180 mg. (22% of theory) of 5,6-dimethoxy-2-(S-nitro-lmethyl-2-imidazolyl-methylcne)-l-indanone; M.P. 258-- 266".

Calculated 58.36 4.50 12.70

Found 58.10 4.70 13.00

EXAMPLE 33 455 mg. of S-hydroxy-G-methoxy-l-indanone was reacted and worked up as described in Example 26, thus obtaining 118 mg. (13% of theory) of 6-methoxy-5-acetoxy- 2-(5-nitro-1-methyl-2-imidazolyl-methylene)-1 indanone; M.P. 258259.

c H N Calculated 57.14 4.24 11.70

Found 57.00 4.54 11.78

EXAMPLE 34 o H N Calculated 5350 4.53 14.33

Found 4. s0 14. 5s

EXAMPLE 35 455 mg. of 4-chloro-7-hydroxy-l-indanone was reacted and worked up as set forth in Example 26, thus producing 292 mg. (32% of theory) of 4-chl0ro-7-acetoxy-2-(5- nitro-1-methyl-2-imidazolyl-methylene)-1-indanone, M.P. 241-242".

Calculated 53. 12 3. 35 11. 62

Found 52.64 3.36 11.78

EXAMPLE 36 600 mg. of 4-chloro-7-acetoxy-2-(5-nitro-1-methyl-2- imidazolyl-methylene)-l-indanone was reacted as described in Example 11. After vacuum-filtering, 530 mg. (99% of theory) of 4-chloro-7-hydroxy-2-(S-nitro-lmethyl-2-imidazolylmethylene)-1-indanone was obtained, M.P. 266-267".

C H N Calculated 52. 59 3. 15 13. 14 Found 52. 3. 17 13. 20

13 EXAMPLE 37 518 mg. of 3-phenyl-l-indanone, 388 mg. of S-nitro-lmethyl-Z-imidazolyl aldehyde, and 350 mg. of anhydrous sodium acetate were allowed to stand for eight hours at a temperature of 100 in 250 ml. of acetic anhydride. After cooling to vacuum-filtering, washing with water, and recrystallization from dimethylformamide, 222 mg. (26% of theory) of 3-phenyl-2-(S-nitro-l-methyl-Z-imidazolylmethylene)-l-indanone was obtained, MJP. 184-186".

C H N Calculated 69. 75 4.10 12. 21 Found 69. 00 4. 74 12. 01

EXAMPLE 38 485 mg. of 6,7-dimethoxy-3-benzofuranone was reacted and worked up as described in Example 26, thus producing 231 mg. (28% of theory) of 6,7-dimethoxy-2-(5-nitro-1- methyl-Z-imidazolyl-methylene)-3 benzofuranone, M.P. 253/ 8-261 Calculated 54.38 3.90 12.09

Found 54.16 4.00 12.50

EXAMPLE 39 370 mg. of 4-chromanone was reacted as set forth in Example 7. After digesting in hot dimethylformarnide and recrystallizing from tetrahydrofuran, mg. (1.4% of theory) of 3-(5-nitro-lmethyl-2-imidazolyl-methylene)- 4-chromanone was obtained, M.P. 215-218.

C H N Calculated 58. 94 3. 89 14. 73

FOund 58. 70 4. 00 14. 48

EXAMPLE 40 410 mg. of 7-hydroxy-4-chromanone was reacted as described in Example 7. After the addiiton of 5 ml. of water, the reaction mixture was cooled to 5, the precipitated product was vacuum-filtered and recrystallized from dimethylformamide/water. 78 mg. (9.2% of theory) of 7- acetoxy-3-(S-nitro-1-methyl-2-imidazolyl-methylene) 4- chromanone was obtained, M.P. 202-203 C H N Calculated 55.65 4.38 12.17

Found 56.75 3.89 12.31

EMMPLE 41 388 mg. (2.5 mmol) of S-nitro-1-methyl-2-imidazolyl aldehyde and 440 mg. (2.5 mmol) of 6-methoxy-1-tetralone were heated in 2.55 ml. of glacial acetic acid and 0.055 ml. of 95% sulfuric acid for 6 hours to 100. After cooling, the reaction liquor was mixed with methanol and vacuum-filtered, thus obtaining 154 mg. (20% of theory) of 6-methoxy-2-(S-nitro-l-methyl 2 imidazolyl-methylene) -1-tetralone, M.P. 215

Calculated 61.33 4.83 13. 41 Found 61. 45 5. 20 13. 27

EXAMPLE 42 415 mg. of 5-chloro-1-indanone was reacted and worked up as described in Example 26, thus producing 20 mg. (2% of theory) of 5-chloro-2-(S-nitro-l-methyl-Z- imidazolyl-methylene)-1-indanone, M.=P. 266/74-276.

C H N Calculated 55. 36 3. 34 13.83 Found 55. 44 3. 31 13. 75

14 EXAMPLE 43 570 mg. (2 mmol) of 5-hydroxy-2-(S-nitro-l-methyl-Z- imidazolyl-methylene)-1-indanone was agitated for 1 hour at 20 with 660 mg. (4 mmol) of cinnamic acid chloride in 8 ml. of pyridine. After dilution with 5 ml. of ethanol, vacuum-filtering of the precipitate, and recrystallization from dimethylformamide, 632 mg. (76% of theory) of S-cinnamoyloxy-Z-(5-nitro-1-methyl 2 imidazolyl-methylene)-1-indanone was obtained; M.P. 252254.

o H N Calculated 00.50 4.13 10.12

Found 00.20 4.46 10.20

EXAMPLE 44 485 mg. (2.5 mmol) of 7-methoxy-4-thiachrornanone was reacted and worked up as described in Example 41, thus obtaining 70 mg. 8.5% of theory) of 7-methoxy-2- (S-nitro-1-methyl-Z-imidazolyl-methylene) 4 thiachrou manone; M.P. 192/l93-198.

Calculated 12.69 9.68 Found 12.56 9.34

EXAMPLE 45 508 mg. (2.5 mmol) of 6-acetylamino-l-tetralone was reacted as described in Example 41, except that the heating step lasted only 5 hours, and then worked up as set forth in that example. 253 mg. (30% of theory) of 6- acetylamino-2-(S-nitro-l-methyl 2 imidazolyl methylene)-1-tetralone was obtained, M.P. 227-228 C.

c H N Calculated 60.00 4.74 16.46

Found 59.91 4.96 10.00

EXAMPLE 46 600 mg. (2.5 mmol) of 6-rnethanesulfonyloxy-l-tetralone was reacted as set forth in Example 41, but heated for 7 hours, and then worked up as described therein, thus obtaining 250 mg. (27% of theory) of G-methane- 405 mg. (2.5 mmol) of 6-hydroxy-1-tetralone was reacted as described in Example 41, but heated only for 3 hours, and then worked up as described therein. mg. (14% of theory) of 6-hydroxy-2-(5-nitro 1 methyl-2- imidazolyl-methylene) 1 tetralone was produced, M.P. 238-240.

c H N Calculated 60.19 4.38 14.04

Found 60.19 4.75 13.76

EXAMPLE 48 365 mg. (2.5 mmol) of l-tetralone was reacted as set forth in Example 41, but heated only for 2% hours, and then worked up as set forth in that example, thus obtaining 30 mg. (4.2% of theory) of 2-(5-nitro-1-methyl-2- imidazolyl-methylene)- 1-tetralone, M.P. 193195.

c H N Calculated 63.59 4.63 14.83 Found 64.01 4.97 14.48

15 EXAMPLE 49 11 g. (78 mmol) of nitro-l-ethyl-imidazole was heated with 11.7 g. of paraformaldehydein 57 ml. of di methyl sulfoxide in a sealed tube for 48 hours to 110". After the volatile components had been distilled off at 1 mm. Hg and a bath temperature of 100, the residue was recrystallized twice from benzene, thus producing 5.1 g. (38% of theory) of S-nitro-l-ethyl-Z-hydroxymethylimidazole; M.P. 101-102".

3.42 g. (20 mmol) of this compound was boiled in 113 ml. of benzene with g. of lead tetraacetate for 8 hours. After cooling, filtering, washing the benzenic solution neutral, and drying the same, the product was evaporated under a vacuum, thus obtaining 2.37 g. (70% of theory) of S-nitro-1-ethyl-2-imidazolyl aldehyde in the form of an oil.

424 mg. (2.5 mmol) of this compound-was reacted with 370 mg. (2.5 mmol) of S-hydroxy-l-indanone, as set forth in Example 7. The crude product was digested with hot ethanol, thus producing 145 mg. (17% of theory) of 5-.

acetoxy-2-( S-nitro-l-ethyl 2 imidazolyl-methylene)-1- indanone, M.P. 225-227 e Calculated 59.82 4.43 12.32

Found 59.50 4.30 12.33

EXAMPDE 5O C H N Calculated 61.19 4.28 11.89

Found 61.62 4.00 12.23

EXAMPLE 51 300 mg. (2.5 mmol) of acetophenone was reacted and worked up as described in Example 41; yield; 335 mg.

(52% of theory) of 2-(5-nitro-l-methyl 2 imidazolylmethylene)-acetophenone, M.P. 202.

C H N Calculated 60.70 4.31 16.34

Found 60.47 4.27 16.33

EXAMPLE 52 340 mg. (2.5 mmol) of 4'-hydroxyacetophenone was reacted and worked up as set forth in Example 41. Yield: 270mg. (40% of theory) of 4-hydroxy-2-(5 nitro-lmethyl 2 imidazolyl-methylene)-acetophenone, M.P.

o H N Calculated 57.15 4.06 15.38 Found 56.76 4.26 15.61

EXAMPLE 53 450 mg; (2.5 mmol) of 4'-(2-hydroxyethoxy)-acetophenone was reacted and worked up as described in Example 41. Yield: 406 mg. (45% of theory) of 4-(2- acetoxyethoxy) 2-(5-nitro-1-methyl-Z-imidazolyl-methylene)-acetophenone, M.P. 163

Calculated 56.82 4.77 11.70

Found 57.10 5.18 11.68

. EXAMPLE 54 405 mg. of 7 methoxy-l-indanone was reacted and worked up as set forth in Example 10. Yield: 191 mg.

(26% of theory) 'of 7 'methoxy-Z-(5-nitro-1-methyl-2-. 1

imidazolyl-methylene)-1-indanone; M.P. 273-282. I

Calculated 60.19 4.38 14.04

Found 59.63 4.57 13.81

EXAMPLE 55 570 mg. of 5-hydroxy-2-(5-nitro-1-methyl-2-imidazoly1- methylene)-1-indanone was mixed in 10 ml. of pyridine with 764 mg. of p-toluenesulfonyl chloride. After allowing the reaction mixture to stand for 1 hour at 20 and'for 1 hour at it was mixedwith ethanol, cooled, and

Calculated., 9.56 g 7.30

Found 9.88 -7.10

EXAMPLE 56 4.8 g. of S-nitro-l-(2-benzoyloxyethyl)-irnidazole was heated with 2.76 g'. of paraformaldehyde in 16.8 ml. of dimethyl sulfoxide in a sealed tube at for 48 hours. Evaporation under vacuum and recrystallization from benzene yielded 2.77 g. (52% of theory) of 5-nitro-2-hy. droxymethyl-1-(2-benzoyloxyethyl)-imidazole, M.P. 136- 139.

5.84 g. of this compound was treated with lead tetraacetate and worked up, as described in Example 49. Yield: 3.95 g. (68% of theory) of 5-nitro1-(2-benzoyloxyethyl)- Z-imidazolyl aldehyde, M.P. 113-114 772 mg. of. this compound was-reacted with 370 mg. of S-hydroxy-l-indanone as described in Example 10 (except that the heating step was conducted for 4 hours), and worked up. Yield: 306 mg. (27% of theory) of 5-acetoxy- 2 [5 nitro-1-(2-benzoyloxyethy1)-2-imidazolyl-methylene]-1-indanone; M.P. 186.5187.5.

410 mg. of 4-thiaehromanone was reacted and worked up as set forth in Example 41, thus obtaining 122 mg.

(12% of theory) of 3 (S-nitro-1-methyl-2-imidazolyl-.

methylene) 4-thiachromanone-1H SO M.P. 189/ 190- 193".

Calculated Found H SO -free compound Melting point: -176-178.

Calculated Found 1 7 EXAMPLE 58 555 mg. of hydroxy-6,7-dimethoxy-l-tetralone was reacted and worked up as described in Example 41, thus obtaining 116 mg. (13% of theory) of 5-hydroxy-6,7- dimethoxy 2- (5-nitro-1-methyl-Z-imidazolyl-methylene l-tetralone; M.P. 246-248.

c H N Calculated 56.82 4.77 11.70

Found 55.79 499 11.35

EXAMPLE 59 Calculated 11.49 9.70

Found 11.32 9.63

EXAMPLE 60 473 mg. of S-acetylamino-l-indanone was reacted and worked up as set forth in Example 57, thus obtaining 193 mg. (24% of theory) of 5-acetylamino-2-(5-nitro-1-methyl-2-imidazolyl-methylene)-1-indanone, M.P. 275-285".

Calculated 58.89 4.33 17.17

Found 58.66 4.53 17.28

EXAMPLE 61 340 mg. (1 mmol) of 6-acetylamino-2-(S-nitro-l-methyI-Z-imidazolyl-methylene)-1-tetralone was boiled in 8 ml. of ethanol and 4 ml. of concentrated hydrochloric acid for 2 hours. After cooling and vacuum-filtering, 169 mg. (56% of theory) of 6-amino-2-(5-nitro-1-rnethyl-2-imidazolyl-methylene)-1-tetralone; M.P. 295.

C H N Calculated 60.39 4.74 18.78

Found 60.20 5.06 19.22

EXAMPLE 62 403 mg. of 6-amino-1-tetralone was reacted and worked up as described in Example 41. Yield: 115 mg. (15% of theory) of 6 amino 2-(5-nitro-l-methyl-2-imidazolylmethylene)-1-tetralone, M.P. 295.

EXAMPLE 63 435 mg. of 5,7-dimethyl-1 tetralone was reacted and Worked up as set forth in Example 41, thus obtaining 179 mg. (23% of theory) of 5,7-dimethyl-2-(5-nitro-l-methyl-2-imidazolyl-methylene)-1-tetralone, M.P. 228-229.

o H N Calculated 55.59 5.51 13.50

Found .51 5. 73 13.45

EXAMPLE 64 568 mg. of 4-bromo-7-hydroxy-l-indanone was reacted as described in Example 57. The product was digested with water and recrystallized from acetonitrile. Yield: 318 mg. (32% of theory) of 4-bromo-7-acetoxy-2-(S-nitro-1- methyl 2-imidazolyl-methylene)-l-indanone; M.P. 248- 251.

N Br

Calculated 10. 35 19. 67 Found 10. 32 19. 96

18 EXAMPLE 55 690 mg. of sodium, 4.44 g. of S-hydroxy-l-indanone, and 7.5 g. of 2-bromoethanol were boiled for 48 hours with a spatula tip amount of potassium iodide in 40 ml. of alcohol. After the solvent had been removed by evaporation under vacuum, the residue was shaken with 50 ml. of water and '50 ml. of ethyl acetate. The thus-produced precipitate was vacuum-filtered and recrystallized from ethyl acetate, thus obtaining 900 mg. (16% of theory) of 5-(2-hydroxyethoxy)-l-indanone, M.P. 121/ 122-127.

480 mg. of 5-(2-hydroxyethoxy)-1-indanone was re acted and worked up as described in Example 57. Yield: mg. 16% of theory) of 5-(2-acetoxyetl1oxy)-2-(5- nitro-1-methyl-2-imidazolyl-methylene)-l-indanone, M.P. 212/215-216".

o H N Calculated 58.22 4.52 11.32

Found 57.33 4.55 11.77

EXAMPLE 66 490 mg. of 5-chloro-4,6-dimethyl-3-benzofuranone was reacted as set forth in Example 57. By recrystallizing the product from tetrahydrofuran, after digesting the product with water, 65 mg. (8% of theory) of 5-chloro-4,6-dimethyl 2 (S-nitro-l-methyl-2-imidazolyl-methylene)-3- benzofuranone was obtained; M.P. 265-271.

N Cl

Calculated 12. 59 10. 63

Found 12.14 10. 61

EXAMPLE 67 Calculated 51.74 5.18 11.38

Found 61.80 5.45 10.81

EXAMPLE 68 455 mg. of thioindoxyl-1,1-dioxide was reacted as set forth in Example 7. After cooling the reaction mixture, filtering same off from sodium acetate, and mixing the filtrate with water, a precipitate was obtained which was recrystallized from acetonitrile. 33 mg. (4% of theory) of 2 (S-nitro-1-methyl-2-imidazolyl-methylene)-thioindoxyl-1,l-dioxide was obtained, M.P. 288.

Calculated 13.15 10. 04

Found 12.83 0. 75

EXAMPLE 69 574 mg. (2 mmol) of 2-(S-nitro-l-methyl-2-imidazolylmethylene)-thioindoxyl was mixed in 50 ml. of glacial acetic acid with 0.5 ml. of 30% hydrogen peroxide (in 10 ml. of glacial acetic acid). After agitating the reaction mixture for 16 hours at 20, another 0.5 ml. of 30% hydrogen peroxide was added thereto. After agitating for 8 hours at 20, the reaction mixture was filtered; the filtrate was evaporated under vacuum, and the residue digested with methanol, thus obtaining 108 mg. (18% 19 of theory) of 2-(S-nitro-1-methyl-2-imidazolyl-methylene)-thioindoxyl-1-oxide; M.P. 256.

Calculated 13.85 10. 56

Found 14. 06 10. 69

EXAMPLE 70 638 mg. of -(2dimethylaminoethoxy)-1-indanone, hydrochloride, was reacted as described in Example 7. After mixing the reaction mixture with water, it was extracted with chloroform. The evaporated chloroform extract was taken up in methanol and mixed with ether. After filtering, the filtrate was evaporated to dryness, and the residue was dissolved in 25 ml. of 2 N hydrochloric acid. After the hydrochloric phase had been washed with ether and ethyl acetate, it was made alkaline with 2 N sodium hydroxide solution, and extracted with chloroform. The residue of the evaporated chloroform extract was diluted with methanol and ether; by vacuum-filtering, 4.7 mg. (0.5% of theory) of S-(Z-dimethylaminoethoxy)-2-(5- nitro-1-methyl-2-imidazolyl-methylene)-1-indanone was obtained, M.P. 223-225 The structure was confirmed by the mass spectrum, exhibiting intensive peaks at 356 (M) and 662 mg. of 5-methoxy-2-(S-nitro-1-methy1-2-imidazolylmethylene)-4-thiachromanone was mixed in 50 ml. of glacial acetic acid with 0.5 ml. of 30% hydrogen peroxide. After agitation of the reaction mixture for 24 hours at 20, 0.5 m1. of 30% hydrogen peroxide was added thereto, and after another 24 hours at 20, a further 0.5 ml. of hydrogen peroxide was introduced. After 72 hours at 20, the reaction mixture was filtered, and the precipitate was recrystallized from acetonitrile. Yield: 259 mg. (30% of theory) of 5-meth0xy-2-(5-nitro-1-methyl-2- imidazolyl-methylene)-4-thiachromanone-l-oxide; M.P. 241/42-245.

Calculated 12.10 9.23

Found 12.05 9.33

EXAMPLE 72 5.95 g. (36.8 mmol) of 6-amino-1-tetralone in 200 ml. of water was mixed dropwise, at 80", simultaneously with 12 ml. of dimethyl sulfate and 6.75 ml. of 50% sodium hydroxide solution After cooling, the reaction mixture was vacuum-filtered and the precipitate triturated with ether. The ether filtrate resulted, after evaporation, in 3 g. of substance which was chromatographed over a silica gel column (150 g.) with petroleum ether/ethyl acetate. First, 473 mg. of 6-dimethylamino-1-tetra1one was obtained, M.P. 66-67", and then 1.21 g. of 6-methylamino-l-tetralone was produced, M.P. 93-94.

473 mg. of 6dimethylamino-l-tetralone was reacted as described in Example 41, thus obtaining 207 mg. (25% of theory) of 6-dimethylamino-2-(S-nitro-l-methyl-Z- imidazolyl-methylene)-1-tetralone, M.P. 239/46-49.

o H N Calculated 62. 57 5. 57 17. 17 Found- 62. 50 5. 73 10. 98

EXAMPLE 73 urn-filtered. Yield: 258 mg. (50% of theory) of S-methoxy 2 (1 methyl 2 imidazolyl-methylene) 1- indanone, M.P. 258-259. 300 mg. of this compound was mixed in 1.6 ml. of nitric acid (sp. gr. 1.4) at 4 with 1.6 ml. of concentrated sulfuric acid. The reaction mixture was boiled for two hours under reflux, cooled to 20, and poured into ice water. Vacuum-filtering resulted in a mixture of substances, from which 40 mg. of S-methoxy- 2 (5 nitro 1 methyl 2 imidazolyl methylene)- l-indanone 11% of theory), M.P. 256259, was obtained by preparative thin-layer chromatography.

EXAMPLE 74 370 mg. (2.5 mmol) of S-hydroxy 1 indanone was treated and worked up as described in Example 41. Yield: 450 mg. of 5 hydroxy 2 (5 nitro 1 methyl 2- imidazolyl-methylene) l indanone (63% of theory), M.P. 292.

EXAMPLE 75 Calculated 58.36 4.00 12.70 Found 58.05 4.85 12.29

EXAMPLE 76 625 mg. (1.92 mmol) of 5 acetylamino 2 (S-nitro- 1 methyl 2 imidazolyl methylene) 1 indanone was boiled for 2 hours in 15.3 ml. of ethanol and 7.7 ml. of concentrated hydrochloric acid. Cooling, vacuum-filtering, and digesting in hot water and thenin hot ethanol resulted in 454 mg. (83% of theory) of 5-arnino-2-(5- nitro 1 methyl 2 imidazolyl-methylene)-1-indanone, M.P. 292.

Calculated 59.14 4.20 19.41 Found 59.14, aas 19.47

EXAMPLE 77 300 mg. (2.5 mmol) of acetophenone was reacted as set forth in Example 7. After cooling, the reaction mixture was filtered to remove sodium acetate and the filtrate mixed with 5 ml. of water. Vacuum-filtering resulted in 53 mg. (8% of theory) of 2 (5 nitro 1 methyl 2- imidazolyl-methylene)-acetophenone, M.P. 202.

EXAMPLE 78 415 mg. (2.5 mmol) of 5,6-dihydroxy 1 indanone was treated and worked up as described in Example 41. Recrystallization from dimethylformamide-methanol resulted in 250 mg. (33% of theory) of 5,6-dihydroxy-2- (5 nitro 1 methyl 2 imidazolyl methylene)1- indanone, M.P.: above 290.

Calculated 55.81 3.68 13.95 Found 55.38 4.05 13.77

EXAMPLE 79 520 mg. (2.5 mmol) of 4 fluoro 7 chloro-3-methyl l-indanone was treated as set forth in Example 7, except that the reaction mixture was allowed to stand for 2% hours at. After cooling, the mixture was mixed with methanol, the crystals were vacuum-filtered, digested in hot water, and recrystallized from acetonitrile. Yield: 103 mg. (12% of theory) of 4 fluoro 7 chloro 3- methyl 2 (5 nitro 1 meth'yl 2 imidazolyl-meth- 375 mg. (2.5 mmol) of 6-hydroxy-3-benzofuranone was treated and worked up as described in Example 41. Yield: 127 mg. (18% of theory) of 6-hydroxy 2 (5-nitro-1- methyl 2 imidazolyl-methylene) 3 benzofuranone; M.P. above 290".

EXAMPLE 81 2.07 g. of sodium was dissolved in 120 ml. of ethanol, and 14.6 g. (90 mmol) of 6-hydroxy-l-tetralone, 22.5 g. of 2-bromoethanol, and 0.4 g. of potassium iodide were added to the reaction mixture. After boiling for 48 hours under a nitrogen atmosphere, the reaction mixture was evaporated to dryness under a vacuum, mixed with 200 ml. of water, and extracted with ethyl acetate. The ethyl acetate solutions were washed with l N hydrochloric acid and water, dried, filtered, and concentrated to dryness. Dilution of the residue with ether resulted in 14.7 g. (79% of theory) of 6-(2 hydroxyethoxy) 1 tetralone, M.P. 89-91".

Calculated 69. 89 6. 85 F01111d 69. 62 7.

Calculated 59.21 4.97 10.91

Found 59.68 5.08 10.69

EXAMPLE 82 438 mg. (2.5 mmol) of fi-methylamino-l-tetralone was treated as set forth in Example 41. After cooling and mixing with methanol, a crystallized product was obtained which was discarded. The filtrate resulted, after 16 hours at 4, in a second crystallized product which was filtered in benzene/acetone, 2:1, over 1 g. of silica gel. After evaporation under vacuum and recrystallization of the residue from isopropanol, 50 mg. (6% of theory) of 6- methylamino 2 nitro 1 methyl 2 imidazolylmethylene)-1-tetralone, M.P. 235 was obtained.

Calculated 17.94 Found 17.89

EXAMPLE 83 388 mg. (2.5 mmol) of 7-hydroxy 4 chromanone was treated and worked up as described in Example 41. Yield: 40 mg. (5% of theory) of 7 hydroxy 3 (5- nitro 1 methyl 2 imidazolyl methylene)-4-chro- 22 EXAMPLE 84 410 mg. (2.5 mmol) of 4 isothiachromanone was treated and worked up as set forth in Example 41. Yield: 156 mg. (21% of theory) of 3 (5 nitro 1 methy1- 2 imidazolyl-methylene) 4 isothiachromanone, M.P. 210.

C H N Calculated 58.22 4.62 11.32

Found 57. 84 4. 59 11. 43

EXAMPLE 86 500 mg. (1.35 mmol) of 5 methoxy 2 [5-nitro-1- (2 acetoxyethyl) 2 imidazolyl-methylene]-1-indanone was boiled in 10.8 ml. of ethanol and 5.4 ml. of concentrated hydrochloric acid for two hours. Cooling, mixing with 5 ml. of water, and vacuum-filtering resulted in 388 mg. (87% of theory) of S-methoxy-Z-[5-nitro-1-(2- hydroxyethyl)-2-imidazolyl-methylene]-l-indanone, M.P. 229.

C H N Calculated 58.36 4. 50 12.76

Found 57.72 4.83 12.94

EXAMPLE 87 264 mg. (2 mmol) of l-indanone was reacted with 1- methyl-2-imidazolyl aldehyde as described in Example 73, yielding 325 mg. (72% of theory) of 2-(1-methyl-2- imidazolyl-methylene)-1-indanone, M.P. 193-195. 300 mg. of this compound was nitrated as described in Example 73. Yield after preparative layer chromatography: 17 mg. (4% of theory) of 2-(5-nitro-1-methyl-2- imidazolyl-methylene)-1-indanone, M.P. 250-251 EXAMPLE 88 3.76 g. (9.86 mmol) of 6 (2 acetoxyethoxy)-2-(5- nitro 1 methyl 2 imidazolyl-methylene)-1-tetralone was boiled in 78 ml. of alcohol and 39 ml. of concentrated hydrochloric acid for two hours. After cooling, the reaction mixture was poured into 234 ml. of water, and the precipitate was vacuum-filtered. Yield: 2.79 g. (83% of theory) of 6-(2-hydroxyethoxy)-2-(5-nitro-1-methyl-2- imidazolyl-methylene)-1-tetra1one, M.P. 229-232".

23 EXAMPLE 90 343 mg. (1 mmol) of 6-(2-hydroxyethoxy)-2-(S-nitro- 1 methyl-Z-imidazolyl-methylene)-l-tetralone was dissolved in 4 m1. of pyridine under slight heating. After the addition of 191 mg. (1 mmol) of p-toluenesulfonyl chloride, the reaction mixture was agitated for 3 hours at room temperature, poured into 20 m1. of ethanol, and vacuum-filtered. Yield: 424 mg. (85% of theory) of 6- (2 p-toluenesulfonyloxyethoxy)-2-(5-nitro1-methyl-2- imidazolyl-methylene)-1-tetralone; M.P. 193-196 Calculated 3.45 0.45

Found 9.04 0.12

EXAMPLE 91 10 g. (0.07 mol) of dimethylaminoethyl chloride hydrochloride and 2.8 g. (0.07 mol) of NaOH were dissolved in 20 ml. of water, extracted with benzene, and the benzenic solution was dried overK CO under agitation for 48 hours.

1.2 g. (0.052 mol) of sodium was dissolved in 50 ml. of ethanol; then, 8.1 g. (0.05 mol) of 6 hydroxy 1- tetralone was added thereto. The freshly prepared solution of dimethylaminoethyl chloride and a spatula tip amount of KI were added to this reaction solution. The latter was stirred for 20 hours under reflux, then decanted off from the precipitated NaCl; the solution was concentrated, the residue was taken up in H and extracted with ethyl acetate. The organic phase was dried over Na SO and concentrated. The oily residue was dissolved in ether and mixed with ethereal HCl. The thus-precipitated solid product was vacuum-filtered and recrystallized from isopropanol. Yield-z 7.4 g. (55% of theory) of 6-(2-din1ethylaminoethoxy)-1-tetralone, hydrochloride; M.P. 173-174".

Calculated 5. 19 13. 13 Found 5. 20 p 13. 19

673 mg. (2.5 mmol) of 6-(2-dimethylaminoethoxy)-1- tetralone, hydrochloride, was reacted as described in Example 41. The reaction mixture was worked up by pouring same into ml. of water, concentrating the reaction solution under vacuum almost to dryness, and diluting the residue with methanol/ether, as well as subsequent vacuum-filtering. Yield: 280 mg. (24% of theory) of 6-(2- dimethylaminoethoxy) 2-(S-nitro-l-methyl-2-imidazolylmethylene)-ltetralone as the sulfate; M.P. 196/200- N p S Calculated 11. 9a 6.85 Found 11.49 7.05

EXAMPLE 92 Calculated 12.09 10.20

Found 11.73 9.35

EXAMPLE 93 718 mg- (2 mmol) of 4'-(2-acetoxyethoxy)-2-(5-nitro- 1 methyl Z-imidazolyl-methylene)-acetophenone was boiled in 16 m1. of ethanol and 8 mLof concentrated Calculated 11.90 9.96

Found 11.80 9.89

EXAMPLE 94 353 mg. (1 mmol) of 4'-(2-hydroxyehyoxy)-2-(5-nitro- 1-methyl-2imidazolyl-methylene) acetophenone, hydrochloride, was reacted as described in Example 90. The reaction mixture was worked up by pouring into 10 ml. of ice water. and vacuum-filtering the crystalline product. Yield: 402 mg. of theory) of 4'-(2-toluenesulfonyloxyethoxy) 2 (5 nitro-1-methyl-Z-imidazoyl-methylene)-acetophenone; M.P. 144-146.

Calculated 8. 91. 6. 80

Found 8. 98 6. 71

EXAMPLE 942 mg. (2 mmol) of 4'-(2-p-toluenesulfonyloxyethoxy) -2-(5 nitro-1-methyl-2-imidazolyl-methylene)-acetophononewas dissolved in 4 ml. of absolute dioxane and, after the addition of 0.2 ml. (2.3 mmol) of morpholine, heated for 2 hours to The reaction mixture was evaporated to dryness under vacuum. The residue was taken, up in 10 m1. of ethyl acetate and 5 ml. of water. The water phase was separated, and the ethyl acetate phase was washed once with water (2 ml.), dried over MgSO and evaporated. The residue was recrystallized from ethyl acetate. Yield: 436 mg. (56% of theory) of 4-(2-morpholinoethoxy 2 (5 nitro-l-methy1-2-imidazoyl-methylene)-acetophenone; M.P. -1615.

C H N Calculated 59. 06 5. 75 14. 50 Found 58. 71 5. 76 14. 15

The product was dissolved in methanol and, by the addition of ethereal hydrochloric acid, the hydrochloride of the compound was precipitated; M.P. 201/205-206".

EXAMPLE 96 c H N Calculated 51.40. 4.49 17.85

Found 50.90 we 18.42.

EXAMPLE 97 1.39 g. (4.42 mmol) of 4'-acetylamino-2-(5-nitro-lmethyl-Z-imidazolyl-methylene)-acetophenone was boiled under reflux in 35.4 ml.of ethanol and 17.7 ml. of concentrated hydrochloric acid for 2 hours. The reaction mixture was cooled and vacuum-filtered. Yield: 684 mg. (52% of theory) of 4-amino-2-(5-nitro-1-methyl-2-imidazolylmethylene) -acetophenone, hydrochloride; M.P. 210 (decomposition).

Calculated 18. 16 11. 48

Found 17. 60 10. 44

EXAMPLE 98 C H N Calculated 58.53 4.57 14.62

Found 58.22 4.83 14.48

EXAMPLE 99 O H N Calculated 53.98 3.84 14.53

Found 53.87 4.15 14.08

EXAMPLE 100 450 mg. (2.5 mmol) of 2,4'-dimethoxyacetophenone was reacted and worked up as described in Example 41. Yield: 219 mg. (27% of theory) of 2,4'-dimethoxy-2-(5- nitrol-methyl 2 imidazolyl methylene)-acetophenone; M.P. 124-l26.

o H N Calculated 56.79 4.71 13.25

Found 57.30 5.16 12.76

EXAMPLE 101 471 mg. (1 mmol) of 4'-(2-p-toluenesulfonyloxyethoxy) -2- (5 nitro-1-methyl-2-imidazolyl-methylene) -acetophenone was dissolved in 2 ml. of absolute dioxane and heated, with the addition of 142 mg. (2 mmol) of pyrrolidine, for 2 hours to 100. The reaction mixture was concentrated to dryness under vacuum, and the residue was taken up in ml. of ethyl acetate and 10 ml. of water. The aqueous phase was separated, and the ethyl acetate phase was washed once with 5 m1. of H 0, dried over MgSO and evaporated. The residue was recrystallized from isopropanol/water, dissolved in methanol, and precipitated with ethereal hydrochloric acid. Yield: 105 mg. (27% of theory) of 4'-(2-pyrrolidinoethoxy)-2-(5-nitro-1- methyl-Z-imidazolyl-methylene) acetophenone, dihydrochloride, M.P. 200-202.

Calculated 12. 64 16. 00 Found 12. 19 15. 58

EXAMPLE 102 200 g. of 6.7-dimetl1oxy-2-(S-nitro-1-methy1-2-imidazolyl-methylene) 3 benzofuranone, 105.34 g. of corn starch, 8.0 g. of white gelatin, 6.5 g. of talc, 0.112 g. of methyl p-hydroxybenzoate, and 0.048 g. of propyl phydroxybenzoate are mixed homogeneously and compressed into tablets of 320 mg. in the usual manner in a tablet compressing machine.

EXAMPLE 103 2.0 g. of 6-hydroxy-2-(S-nitro-l-methyl-Z-imidazolylmethylene)-4-tetralone, 27.0 g. of lactose, 45.565 g. of

corn starch, 4.0 g. of talc, 1.4 g. of white gelatin, 0.024 g. of methyl p-hydroxybenzoate, and 0.011 g. of propyl phydroxybenzoate are mixed homogeneously and compressed into tablets of mg. in the usual manner in a tablet compressing machine.

EXAMPLE 104 10 g. of 6-acetoxy-5-methoxy-2-(5-nitro-1 methyl 2- imidazolyl-methylene)-1-indanone, 60 g. of lactose, 4.9 g. of corn starch, 800 mg. of magnesium stearate, 8 mg. of methyl p-hydroxybenzoate, and 3.5 mg. of propyl p hydroxybenzoate are mixed homogeneously and processed in the usual manner by compressing into vaginal tablets of 750 mg.

EXAMPLE 105 11.5 g. (70 mmol) of diethylaminoethyl chloride hydrochloride and 2.8 g. (70 mmol) of NaOH were dissolved in 20 ml. of water, extracted with benzene, and the benzenic solution was dried for 48 hours under stirring, over potassium carbonate. 1.2 g. (52 mmol) of sodium was dissolved in 50 ml. of ethanol, and then 7.4 g. '(50 mmol) of S-hydroxy-l-indanone was added thereto. The freshly prepared solution of diethylaminoethyl chloride and a spatula tip amount of potassium iodide were added to this reaction solution. The reaction mixture was stirred under reflux for 24 hours; then, the reaction mixture was evaporated to dryness under vacuum, the residue was taken up in water, and extracted with ethyl acetate. The organic phase was dried over magnesium sulfate and concentrated. The oily residue was dissolved in ether and mixed with ethereal HCl. The thus-precipitated solid product was vacuum-filtered.

Yield: 8.66 g. (61% of theory) of S-(Z-diethylaminoethoxy-l-indanone, hydrochloride; M.P. 173-175 567 mg. (2 mmol) of 5-(2-diethylaminoethoxy)-1- indanone, hydrochloride, and 310 mg. (2 mmol) of 5- nitro-1-methyl-2-imidazolyl aldehyde were stirred in 2.04 ml. of glacial acetic acid and 0.121 ml. (2.2 mmol) of concentrated sulfuric acid for 6 hours at The reaction mixture was evaporated almost to dryness under vacuum, the residue was diluted with methanol, and the crystalline solid product was vacuum-filtered. Yield: 334 mg. (35% of theory) of 5-(Z-diethylaminoethoxy)-2-(5- nitro-1-methyl-2-imidazolyl-methylene) 1 indanone, sulfate; M.P. 194-1965".

EXAMPLE 106 9.6 g. (50 mmol) of 5-(2-hydroxyethoxy)-l-indanone and 9.5 g. (50 mmol) of p-toluenesulfonyl chloride were stirred in 100 ml. of pyridine for 1.5 hours at room temperature. The reaction mixture was poured into 500 ml. of ice water, and the crystalline solid product was vacuumfiltered. Yield: 12.2 g. of 5 (2 p toluenesulfonyloxyethoxy)-1-indanone (70% of theory); M.P. 94 C.

6.92 g. (20 mmol) of 5 (2 p toluenesulfonyloxyethoxy)-1-indanone and 5.68 g. (80 mmol) of pyrrolidine were boiled under reflux in 200 ml. of ethanol for 3 hours. After evaporating to dryness under vacuum, the reaction product was taken up in water and 2 N NaOH and extracted with ethyl acetate. The organic phase was dried over MgSO. and concentrated. The oily residue was dissolved in ether and mixed with ethereal HCl. The thusprecipitated solid product was vacuum-filtered. Yield: 2.5 g. (45% of theory) of 5-(2-pyrrolidinoethoxy)-l-indanone, hydrochloride.

2.5 g. (8.9 mmol) of 5-(2-pyrrolidinoethoxy)-l-indanone, hydrochloride, and 1.38 g. (8.9 mmol) of S-nitro-lmethyl-Z-imidazolyl aldehyde were reacted as described in Example and worked up.

Yield: 0.75 g. (18% of theory) of 5-(2-pyrrolidinoethoxy)-2-(5 nitro-1-methyl-2-imidazolyl-methylene)-1- indanone, sulfate; 224-225".

EXAMPLE 107 1.38 g. (4 mmol) of -(2-p-toluenesulfonyloxyethoxy)- l-indanone and 1.36. g. (16 mmol) of piperidine were reacted in 40 ml. of ethanol and worked up, as described in Example 106. Yield: 0.96 g. of 5-(2-piperidinoethoxy)-lindanone hydrochloride (81% of theory), M.P. 188- 190.

3 87 mg. (3 mmol) of 5-(Z-piperidinoethoxy)-1-indanone, hydrochloride, and 465 mg. (3 mmol) of 5-nitro-1- methyl-Z-irnidazolyl aldehyde were reacted and worked up as set forth in Example 105. Yield: 340 mg. (23% of theory) of 5-(2-piperidinoethoxy)-2-(5-nitro-1-methyl-2- imidazolyl-methylene) 1 indanone, sulfate; M.P. 224- 226.

EXAMPLE 108 1.38 g. (4 mmol) of 5-(2-p-toluenesulfonyloxyethoxy)- l-indanone and 1.6 g. 16 mmol) of l-methylpiperazine were reacted in 40 ml. of ethanol and worked up, as describedin Example 106. Yield: 1.17 g. (94% of theory) of 5-[2-(4-methylpiperazino)-ethoxy]-1-indanone, hydrochloride; M.P. 234-236".

1.09 g. (3.5 mmol) of 5-[2-(4-methylpiperazino)- ethoxy] l indanone, hydrochloride, and 0.543 g. (3.5 mmol) of S-nitro-1-methyl-2-imidazolyl aldehyde were reacted and worked up as set forth in Example 105. Yield: 0.55 g. (31% of theory) of 5-[2-(4-methylpiperazino)- ethoxy1-2-(S-nitro-l-methyl 2 imidazolyl]-methylene)- l-indanone, sulfate; M;P. 206-209.

EXAMPLE 109 1.73 g. (5 mmol) of 5-(2-p-toluenesulfonyloxyethoxy)- l-indanone and 1.75 g. (20 mmol) of morpholine were reacted in 30 ml. of ethanol and worked up, as described in Example 106. Yield: 1.18 g. (77% of theory) of 5-(2- morpholinoethoxy)-1-indanone, hydrochloride; M.P. 218- 222.

1.1 g. (3.7 mmol) of 5-(2-morpholinoethoxy)-1-indanone, hydrochloride, and 0.574 g. (3.7 mmol) of S-nitrol-methyl-Z-imidazolyl aldehyde were reacted as set forth in Example 105 and worked up. Yield: 0.51 g. (27% of theory) of 5-(2-morpholinoethoxy)-2(5-nitr0 1 methyl 2 imidazolyl-methylene)-l-indanone, sulfate; M.P.

EXAMPLE 110 1.38 g. (4 mmol) of 5(2-p-toluenesulfonyloxyethoxy)- l-indanone and 1.58 g. (16 mmol) of perhydroazepine were reacted in 40 m1. of ethanol and worked up, as described in Example 106. Yield: 0.67 g. (54% of theory) of 5-[2-(l-perhydroazepinyl)-ethoxy]-1-indanone, hydrochloride; M.P. 177-179".

618 mg. (2 mmol) of 5-[2-(l-perhydroazepinyD-ethoxy]-1-indanone, hydrochloride, and 310 mg. (2 mmol) of 5-nitro 1 methyl-Z-imidazolyl aldehyde were reacted and worked up as described in Example 105. Yield: 210 mg. (21% of theory) of 5-[2-(1-perhydroazepinyl)-ethoxy]-2-(5-nitro-l-methyl 2 imidazolyl-methylene)-l-indanone, sulfate; M.P. 212-214.

EXAMPLE 11 1 4.92 g. (33.3 mmol) of 4-hydroxy-1-indanone was reacted with dimethylaminoethyl chloride and worked up, as set forth in Example 105. Yield: 4.4 g. (52% of theory) of 4-(2-dimethylaminoethoxy)-l-indanone, hydrochloride; M.P. 184-186".

637 mg. (2.5 mmol) of 4-(Z-dimethylaminoethoxy)-1- indanone, hydrochloride, and 388 mg. (2.5 mmol) of 5- nitro-l-methyl- 2 -imidazolyl aldehyde were reacted and worked up as described in Example 105. Yield: 750 mg. (66% of theory) of 4-(2-dimethylaminoethoxy)-2-(5-nitro-l-methyl 2 imidazolyl-methylene)-1-indanone, sulfate; M.P. 225-227 3 28 EXAMPLE 112 5.44 g. (37 mmol) ofS-amino-l-indanone in 25 ml. of I I Water was mixed dropwise at simultaneously with 36 ml. of dimethyl, sulfate and 15.5 g. of NaOH in 60 ml.

of water. After cooling, the. reaction mixture was extracted with ethyl acetate. The organic phase was dried over MgSO and concentrated. After recrystallization of the residue from 50% aqueous methanol, 1.2 g. (19% of 128 mg. (16% of theory) of S-dimethylamino-Z-(S-nitro- 1 methyl 2 imidazolyl methylene)-l-indanone; M.P. 290.

EXAMPLE 113 19.27 g. (93.5 mmol) of 6-(2-hydroxyethoxy)-1-tetralone was reacted with 19.5 g. (102.85 mmol) of p-toluenesulfonyl chloride and worked up, as described in Example 106. Yield: 28.6 g. of theory) of 6-(2-ptoluenesulfonyloxyethoxy)-1-tetral0ne; M.P. 106-108".

3.6 g. (10 mmol) of 6-(2-p-toluenesulfonyloxyethoxy)- l-tetralone and 3.48 g. (40 mmol) of morpholine were reacted and worked up as described in Example 106. Yield: 1.73 g. (56% of theory) of 6-(2-morpholinoethoxy)-1- tetralone, hydrochloride; M.P. 194-196".

1.87 g. (6 mmol) of6-(2-morpholinoethoxy)-1-tetralone, hydrochloride, and 0.93 g. (6 mmol) of S-nitro-I- methyl-2-imidazolyl aldehyde were agitated in 6.12 ml. of glacial acetic acid and 0.363 ml. (6.6 mmol) of concentrated sulfuric acid for 6 hours at After cooling, the reaction mixture was mixed with methanol and vacuum-filtered, thus producing 1.04 g. (34% of theory) of 6-(2-morpholinoethoxy)-2-(5-nitro-1-methy1- 2 imidazoyl-methylene)-1-tetralone, sulfate; M.P. 223-224.

EXAMPLE 114 3.6 g. (10 mmol) of 6-(2-p-toluenesulfonyloxyethoxy)- l-tetralone and 2.84 g. (40 mmol) of pyrrolidine were reacted and worked up as described in Example 106. Yield: 2.28 g. (77% of theory) of 6-(2 pyrrolidino ethoxy)-1-tetralone, hydrochloride; M.P. 200-203".

591 mg. (2 mmol) of 6-(2-pyrrolidinoethoxy)-1-tetralone, hydrochloride, and 310 mg. (2 mmol) of 5-nitro-1- methyl-Z-ir'nidazolyl aldehyde were reacted and worked up as described in Example 105. Yield: 216 mg. (22% of theory) of 6 (2 pyrrolidinoethoxy)-2-(5-nitro-1- methyl-2 imidazolyl methylene)-1-tetralone, sulfate; M.P. 198-200".

EXAMPLE 115 473 mg. (2.5 mmol) of S-acetamino-l-indanone and 423 mg. (2.5 mmol) of S-nitro-l ethyl Z-imidazolyl aldehyde were reacted as set forth in Example 7. The crude product was digested with methanol, thus obtaining 206 mg. (24% of theory) of 5-acetamino-2 (S-nitro-lethyl-2-imidazolyl-methylene) 1 indanone; M.P. 268- 269.

EXAMPLE 116 680 mg. (2 mmol) of S-acetamino-Z-(S-nitro-l-ethyl-Z- imidazolyl-methylene)-l-indanone was reacted as described in Example 76, thus obtaining 550 mg. (92% of theory) of 5-amino-2-(S-nitro-l-ethyl 2 imidazolylmethylene)-1-indanone; M.P. 290

EXAMPLE 117 4.73 g. (25 mmol) of S-acetamino-l-indanone and 4.92 g. (25 mmol) of S-nitro-1-butyl-2-imidazolyl aldehyde were reacted and worked up as described in Example 115. Yield: 2.19 g. (24% of theory) of 5-acetamino-2-(5-nitro- 1-butyl-2-imidazolyl-methylene)-1-indanone; M.P. 240- 242.

29 EXAMPLE 118 736 mg. (2 mmol) of S-acetamino-Z-(-nitro-1-butyl-2- imidazolyl-methylene)-1-indanone was reacted as described'in Example 76. Yield: 444 mg. (68% of theory) of 5-amino-2-(5-nitro-1-butyl-2-imidazolyl-methylene)-1- indanone, hydrochloride; M.P. 222.

EXAMPLE 119 4.73 g. (25 mmol) of 5-acetamino-1-indanone and 5.68 g. (25 mmol) of S-nitro-1-(2-acetoxyethyl)-2-imidazolyl aldehyde were reacted and worked up as set forth in Example 115. Yield: 2.27 g. (23% of theory) of 5-acetamino-2-[S-nitro-1-(2-acetoxyethyl)-2-imidazolyl-methylene]-1-indanone; M.P. 227-228.

EXAMPLE 120 290 mg. (0.73 mmol) of 5-acetamino-2-[5-nitro-1-(2- acetoxyethyl)-2-imidazolyl-methylene]-1-indanone was reacted as described in Example 76. Yield: 166 mg. (73% of theory) of 5-amino-2-[5-nitro-1-(2-hydroxyethyl)-2- imidazolyl-methylene]-l-indanone; M.P. 290-292.

EXAMPLE 121 353 mg. (1 mmol) of 4-(2-hydroxyethoxy)-2-(5-nitro- 1-methyl-2-imidazolyl-methylene) acetophenone, hydrochloride, was reacted and worked up as described in Example 92. Yield: 280 mg. (83% of theory) of 4-(2- chloroethoxy)-2-(5-nitro-1-methyl-2-imidazolyl methylene)-acetophenone; M.P. 130-132".

EXAMPLE 122 264 mg. (0.55 mmol) of 4'-(2-p-toluenesulfonyloxyethoxy) -2-(5-nitro-1-methyl-2-imidazolyl-methylene) acetophenone was reacted with 0.11 ml. (1.26 mmol) of morpholine and worked up, as described in Example 101. Yield: 236 mg. (97% of theory) of 4'-(2-morpholinoethoxy)-2-(S-nitro-1-methyl-2-imidazolyl-methylene) acetophenone, hydrochoride; M.P. 186-190.

EXAMPLE 123 1.8 g. mmol) of 4'-(2-hydroxyethoxy)-acetophenone and 1.9 g. (10 mmol) of p-toluenesulfonyl chloride were stirred in 20 ml. of pyridine for 2 hours at room temperature, then poured into 100 ml. of water, and the crystalline solid product was vacuum-filtered. Yield: 2.1 g. (61% of theory) of 4'-(2-p-toluenesulfonyloxyethoxy)- acetophenone; M.P. 82-84".

1.67 g. (5 mmol) of 4'-(2-p-toluenesulfonyloxyethoxy)-acetophenone and 1.42 g. (20 mmol) of pyrrolidine were reacted and worked up as described in Example 106. Yield: 0.7 g. (82% of theory) of 4-(2-pyrrolidinoethoXy)-acetophenone, hydrochloride; M.P. 128-130.

674 mg. (2.5 mmol) of 4'-(2-pyrrolidinoethoxy)-acetophenone, hydrochloride, and 388 mg. (2.5 mmol) of 5- nitro-l-methyl-Z-imidazolyl aldehyde were reacted and worked up as set forth in Example 105. Yield: 503 mg. (43% of theory) of 4-(2-pyrrolidinoethoxy)-2-(5-nitro- 1-methyl-2-imidazolyl-methylene)-acetophenone, sulfate; M.P. 182-184.

EXAMPLE 124 6.8 g. (50 mmol) of 4-hydroxyacetophenone was reacted with dimethylaminoethyl chloride and worked up, as described in Example 105. Yield: 4.3 g. (35% of theory of 4'-(2-dimethylaminoethoxy)-acetophenone, hydrochloride; M.P. 162-163.

608 mg. (2.5 mmol) of 4'-(Z-dimethylaminoethoxy)- 'acetophenone, hydrochloride, and 388 mg. of 2.5 mmol) of 5-nitro-1-methyl-2-imidazolyl aldehyde were reacted and worked up as described in Example 113. Yield: 497 mg. (45% of theory) of 4'-(Z-dimethylaminoethoxy)-2- (5 -nitro- 1 -methyl-2-imid azolyl-methylene -acetophenone, sulfate; M.P. 183185.

30 EXAMPLE 12s 5 g. (37 mmol) of 4-aminoacetophenone in 25 ml. of Water was mixed dropwise at simultaneously with 12 ml. of dimethyl sulfate and 5.15 g. of NaOH in 20 ml. of Water. After cooling, the reaction mixture was vacuumfiltered, and the precipitate was recrystallized from 70% aqueous methanol, thus obtaining 4.2 g. of 4'-dimethylaminoacetophenone (70% of theory); M.P. 102-103".

408 mg. of 2.5 mmol) of 4'-dimethylaminoacetophenone and 388 mg. (2.5 mmol) of 5-nitro-1-methyl-2- imidazolyl aldehyde were reacted and worked up as described in Example 41. Yield: 250 mg. (33% of theory) of 4'-dimethylamino-2-(S-nitro-l-methyl 2 imidazolylmethylene)-acetophenone; M.P. 237-238".

EXAMPLE 126 EXAMPLE 127 637 mg. (2.5 mmol) of 5-(2-dimethylaminoethoxy)-1- indanone, hydrochloride, and 388 mg. (2.5 mmol) of 5- nitro-1-methyl-2-imidazoly1 aldehyde were agitated in 2.55 ml. of glacial acetic acid and 0.151 ml. (2.75 mmol) of concentrated sulfuric acid for -6 hours at After cooling, the reaction mixture was mixed with methanol and vacuum-filtered, thus obtaining 379 mg. (33% of theory) of 5-(Z-dimethylaminoethoxy)-2 (5 nitro 1- methyl-Z-imidazolyl-methylene) 1 indanone, sulfate; M.P. 208-210.

o H N s Calculated 47.57 4.88 12.32 7.06

Found 47.46 5.00 12.50 6.91

EXAMPLE 128 200 g. of 6-(2-dimethylaminoethoxy)-2-(5 nitro 1- methyl-Z-imidazolyl-methylene)-1-tetralone hydrogen sulfate; 105.34 g. of corn starch; 8.0 g. of gelatin, white; 6.5 g. of talc; 0.112 g. of methyl p-hydroxybenzoate; and 0.048 g. of propyl p-hydroxybenzoate are mixed homogeneously and pressed into oral tablets of 320 mg. in the usual manner on a tableting press.

'EXAMPLE 129 2.0 g. of 6-(2-morpholinoethoxy)-2-(5-nitro-1-methyl- Z-imidazolyl-methylene) 1 tetralone hydrogen sulfate; 27.0 g. of lactose; 45.565 g. of corn starch; 4.0 g. of talc; 1.4 g. of gelatin, white; 0.024 g. of methyl p-hydroxybenzoate; and 0.011 g. of propyl p-hydroxy-benzoate are mixed homogeneously and pressed into oral tablets of 80 mg. in the usual manner on a tableting press.

EXAMPLE 130 10 g. of 6-(2-morpholinoethoxy)-2-(S-nitro-l-methyl- Z-imidazolyl-methylene)-1-tetralone hydrogen sulfate; 60 g. of lactose; 4.9 g. of corn starch; 800 mg. of magnesium stearate; 8 mg. of methyl p-hydroxybenzoate; and 3.5 mg. of propyl p-hydroxybenzoate are mixed homogeneously and pressed into vaginal tablets of 750 mg. in the usual manner.

31 EXAMPLE 131 For the treatment of Trichomonas vaginalis, administer orally one tablet of Example 128 or 129, 1 to 2 times daily until the infection has cleared, usually 3 to 10 days.

EXAMPLE 132 For the treatment of Trichomonas vaginalis, administer vaginally one tablet of Example 130, 1 to 2 times daily until the infection has cleared, usually 3 to 10 days.

The preceding examples can be repeated with similar success by substituting the generically and specifically described retctants and/or operating conditions of this invention for those used in the preceding examples.

From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

What is claimed is:

1. A pharmaceutical composition useful for treating Trichomonas vaginalis comprising about 0.052.0 g. per unit dosage of a compound of the formula A B1 l l OQN CH=C wherein X is a saturated or unsaturated hydrocarbon group containing 1 to 5 carbon atoms, or a free or esterified 2-hydroxyethy1 group; Y and Z each are hydrogen atoms or, collectively, (a) -CH (b) one of -O, --S, -SO and SO (c) a combination of (a) and one of (b); (d) -CH -CH or (e) -CHA-, wherein 'A is --CH -C H or -C H R R and R each are H, alkyl of l-S carbon atoms, halogen, hydroxy, esterified hydroxy wherein the ester group is an ester of an aliphatic or aromatic carboxylic or sulfonic acid of 1 to 10 carbon atoms, etherified hydroxy wherein the ether group is alkoyx of 1 to 5 carbon atoms, alkyloxy or benzyloxy, and additionally, R, can be alkyl of 1-5 carbon atoms substituted in the terminal position by halogen, hydroxy or esterified or etherified hydroxy as defined hereinabove, amino, alkylamino or dialkylamino wherein alkyl is of 1 to 5 carbon atoms, or heterocyclic amino containing 4 to 14 carbon atoms, up to 3 rings and 1 to 3 N-, O and S heteroatoms, including the amino nitrogen atom, aminoalkoxy wherein alkoxy contains 2 to 5 carbon atoms and amino is an amino group as defined hereinabove, or acylamido wherein acyl is the acyl radical or an aliphatic or aromatic carboxylic or sulfonic acid as defined hereinabove, or a pharmaceutically acceptable acid addition or quaternary ammonium salt thereof, in admixture with a pharmaceutically acceptable carrier.

2. The composition of claim 1 wherein X is saturated or unsaturated alkyl of 1-5 carbon atoms, Z-hydroxyethyl, 2-benzoyloxyethyl, or 2-alkanoyloxyethyl wherein alkanoyl is of 2-3 carbon atoms; R is hydrogen, halogen,

alkyl of 1-5 carbon atoms, a hydroxy, alkanoyloxy group of 2-3 carbon atoms, or saturated or unsaturated alkoxy group of 1-5 carbon atoms; and R is hydrogen, halogen, alkyl of 1-5 carbon atoms, a hydroxy, alkanoyloxy of 2-3 carbon atoms, saturated or unsaturated alkoxy group group of 1-2 carbon atoms, p-toluenesulfonyloxy, benzyloxy, amino, alkanoylamino of 2-3 carbon atoms, benzoylamino, p-toluenesulfonylamino, monoamino or dialkylamino wherein alkyl is of 1-2 carbon atoms, benzylamino or an alkoxy group of 2-4 carbon atoms substituted in the terminal position by one of chlorine, hydroxy, alkanoyloxy of 2-3 carbon atoms, p-toluenesulfonyloxy, or

wherein A and B each are hydrogen, or saturated or unsaturated alkyl of 1-5 carbon atoms, or A and B collectively with the N-atorn are pyrrolidino, piperidino, morpholino, piperazino, or piperazino substituted on the 4-position nitrogen atom by alkyl of 1-5 carbon atoms, hexamethylenimino, heptamethylenimino or octamethylenimino, or a corresponding alkylenimino group bridged directly or by lower alkylene.

3. The composition of claim 1 wherein Y and Z each are hydrogen.

4. The composition of claim 1 wherein Y and Z each collectively are CH 5. The composition of claim 1 wherein Y and Z each collectively are -CH CH 6. The composition of claim 1 wherein the active compound is 6-acetylamino-2-(S-nitro-l-methyl-Z-imidazolylmethylene)-1-tetralone.

7. The composition of claim 1 wherein the active compound is 6-dimethylaminoethoxy)-2-(5-nitro-1-methyl2- imidazolyl-methylene)-1-tetralone or a pharmaceutically acceptable acid addition salt thereof.

8. The composition of claim 1 wherein the active compound is 6(2-morpholinoethoxy)-2-(5-nitro-1-methyl-2- imidazolyl-methylene)-l-tetralone or a pharmaceutically acceptable acid addition salt thereof.

9. The composition of claim 1 wherein the active compound is 6-(2-pyrrolidinoethoxy)-2-(5-nitro-1-methyl-2- imidazolyl-methylene)-1-tetralone or a pharmaceutically acceptable acid addition salt thereof.

10. A process for the treatment of tn'chomoniasis which comprises administering to the infected patient an etfective amount of the composition of claim 1.

ALBERT T. MEYERS, Primary Examinr F. E. WADDELL, Assistant Examiner US. Cl. XJR.

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3,814,810 Dated June 4, 1974 Inventor(s) Clemens Rufer, et a1.

It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

IN THE CLAIMS:

CLAIM l, COLUMN 31, LINE l2 AFTER THE FORMULA:

"alkoyx" should read alkyloxy CLAIM 2, COLUMN 32, LINE 6 After "of"; insert 1-5 carbon atoms, cinnamoyloxy,

alkylsulfonyloxy group of Signed and sealed this 1st day of October 1974.

(SEAL) Attest: I

MCCOY M. GIBSON JR. c. MARSHALL DANN Attesting Officer Commissioner of Patents FORM F'O-105O (10-69) USCOMM-DC 6O376-P69 U.S. GOVERNMENT PRINTING OFFICE 989 036633l, 

